VC fund dedicated to psychedelic meds launches in UKIn the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – Share XVC fund dedicated to psychedelic meds launches in UKhttps://pharmaphorum.com/news/vc-fund-dedicated-to-psychedelic-meds-launches-in-uk/
Olive Tree Ventures closes $170m dedicated digital health fundIsrael’s specialist venture capital firm, Olive Tree Ventures (OTV) has closed a fund worth $170 million, with plans Share XOlive Tree Ventures closes $170m dedicated digital health fundhttps://pharmaphorum.com/news/olive-tree-ventures-closes-170m-dedicated-digital-health/
VC firm SR One completes GSK spin-out, raising $500mTrans-Atlantic biotech venture capital firm SR One has completed its spin-out from GlaxoSmithKline and closed its first fund Share XVC firm SR One completes GSK spin-out, raising $500mhttps://pharmaphorum.com/news/vc-sr-one-completes-gsk-spin-out-raising-500m/
Kyowa Kirin backs €125m life science fund closed by Fountain HealthcareIreland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund – Share XKyowa Kirin backs €125m life science fund closed by Fountain Healthcarehttps://pharmaphorum.com/news/kyowa-kirin-backs-e125m-life-science-fund-closed-by-fountain-healthcare/
Agents for change: the women breaking through in life sciences venture capitalFor a long time, venture capital (VC) firms have been controlled mainly by men. But things are changing Share XAgents for change: the women breaking through in life sciences venture capitalhttps://pharmaphorum.com/views-analysis-sales-marketing/agents-for-change-the-women-breaking-through-in-life-sciences-venture-capital/
European VCs ‘actively seeking new healthcare investments’The disruption caused by the coronavirus crisis hasn’t dampened the enthusiasm of European venture capitalists to make funding Share XEuropean VCs ‘actively seeking new healthcare investments’https://pharmaphorum.com/news/european-vcs-actively-seeking-new-healthcare-investments/
BMS backs record $600m European venture fund closed by LSPVenture capital group Life Science Partners has closed its sixth investment round, raising a record $600 million that Share XBMS backs record $600m European venture fund closed by LSPhttps://pharmaphorum.com/news/bms-backs-record-600m-european-venture-fund-closed-by-lsp/
VC digital health funding reached record $2.5bn in Q1Roche’s $1.9bn Flatiron Health buy was standout deal Share XVC digital health funding reached record $2.5bn in Q1https://pharmaphorum.com/news/vc-digital-health-funding-reached-record-2-5bn-q1-report/